MALAT1 and colorectal carcinoma: In contrast, several studies have reported significantly lower MALAT1 expression in metastatic than primary breast cancer tumor tissue and have reported a positive correlation between MALAT1 overexpression and better patient survival, suggesting a tumor suppressive role of MALAT1 in CRC and breast cancer (21, 36, 37).